Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of Postlabeling Delay on Arterial Spin-Labeling MRI-Based Measures of Cerebral Blood Flow in a Simultaneous PET/MRI Study of Aging.

AJNR. American journal of neuroradiology·2026
Same author

Digital maze test reveals cognitive performance patterns associated with amyloid-β and tau.

Neuropsychology·2026
Same author

Why it should be "Alzheimer disease" rather than "Alzheimer's disease".

Free neuropathology·2026
Same author

Amyloid spatial extent with florbetapir-PET for early detection of preclinical Alzheimer's disease.

The journal of prevention of Alzheimer's disease·2026
Same author

Human Cerebral Cortex Organization Characterized by Functional PET-FDG "Metabolic Connectivity".

bioRxiv : the preprint server for biology·2026
Same author

A Cross-modality Transformer Network for MR-guided Low-dose Tau PET Image Denoising.

IEEE transactions on radiation and plasma medical sciences·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Charles D Chen1, Cinthya Aguero2, Alexandra N Melloni2

  • 1Massachusetts General Hospital, Charlestown, MA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

粉样β和的正电子发射断层扫描 (PET) 生物标志物预测大脑病理,但由于异常值,tau PET需要仔细解释. 个性化的tau PET指标可以改善预测衰老和临床前阿尔茨海默病 (AD) 中的神经病理学评估的预测.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经成像是一种神经成像.
  • 神经病理学神经病理学
  • 阿尔茨海默氏症疾病研究研究

背景情况:

  • 哈佛老化大脑研究 (HABS) 调查了正常老化和临床前阿尔茨海默病 (AD) 之间的差异.
  • 16名HABS参与者捐赠了他们的大脑进行神经病理学评估.
  • 这项研究评估了死前PET生物标志物对神经病理发现的预测能力.

研究的目的:

  • 为了比较死前PET生物标志物与死后神经病理学评估的粉样β和.
  • 确定PET成像可以在多大程度上预测神经病理变化的空间分布和密度.
  • 为了确定PET成像和神经病理学之间的潜在差异,特别是在TAU PET.

主要方法:

  • 神经病理学评估包括粉样β斑块 (Thal阶段/A分数),团 (Braak NFT阶段/B分数) 和神经斑块 (CERAD NP分数/C分数).
  • 粉样βPET (PiB) 度量包括前部,侧部部,顶部和后皮层分布体积比率 (DVR) 和空间范围 (EXT).
  • 陶皮特 (flortaucipir,FTP) 度量包括整个叶,中叶 (MTL) 和叶新皮质 (NEO-T) 的标准化吸收值比率 (SUVR),分析双边和侧面.

主要成果:

  • 粉样βPET (PiB) 度量 (DVR和EXT) 与粉样β斑块得分 (A和C) 有显著的相关性.
  • 最初的tau PET (FTP) SUVR与布拉克NFT阶段 (B分数) 并没有显著的相关性.
  • 排除异常值后,整个时间和NEO-T SUVR与B评分有显著的相关性;横向的SUVR进一步加强了这些相关性.

结论:

  • 粉样蛋白-β PET指标准确地反映了粉样蛋白斑块的分布和密度.
  • 陶氏PET指标与陶氏纠分布相关,但需要去除异常值,这表明可能存在差异.
  • 针对异质性的个性化tau PET指标被提议用于提高神经病理评估的预测.